Ajinomoto enters US medical foods market with Cambrooke Therapeutics acquisition

d007b1c1-fd67-4634-8a60-b76bdb1f45dearticleimage.jpg

09 Nov 2017 --- Ajinomoto Co. Inc has acquired an equity position in US medical foods company Cambrooke Therapeutics, Inc through Ajinomoto North America, Inc. (Ajina) for approximately US$64 million and made it a wholly owned subsidiary. Founded in 2000, Cambrooke develops and manufactures medical foods for patients with amino acid metabolism disorders and other customers. 

It also makes products such as medical foods for patients with intractable epilepsy and low-protein foods for patients with kidney and liver diseases, as well as rolling out its product lineup outside the US in Europe and elsewhere. 

The medical nutrition innovator says it uses original ingredients to develop products that are superior to competing products in taste, digestibility and has achieved a high rate of growth exceeding 20 percent annually for the past three years.

The market for medical foods in the US is the largest in the world at US$1,750 million in 2016, with a solid compound annual growth rate (CAGR) of approximately 10 percent.

The category of foods for patients with metabolic disorders accounts for about 40 percent of this market at US$660 million and is growing at an annual rate of 10 percent, estimates Ajinomoto. 

Patients with metabolic disorders are unable to ingest regular foods and must eat only specified medical foods on a daily basis, but the palatability and lack of variety of these foods has been a major issue.

For years, Ajinomoto Co. has sold amino acids into the medical foods market as ingredients. With this acquisition, the company will make a full-scale entry into that market. 

It says that by applying its scientific knowledge of amino acids’ nutritional and physiological functions, “deliciousness technologies” and food application technologies to Cambrooke’s operations, it will offer enhanced foods to patients with metabolic disorders. 

Increase market share
In addition, by adding to the disease areas covered and using its sales channels outside Japan to strengthen Cambrooke’s overseas rollout, Ajinomoto Co. aims to expand its share of the global market for medical foods for patients with amino acid metabolism disorders to 20 percent, with sales of approximately US$90 million by 2027.

Moreover, by incorporating Cambrooke’s knowledge of the medical foods business into Ajinomoto Co.’s food-related businesses in Japan and overseas, including processed foods, healthcare foods and supplements, Ajinomoto Co. intends to expand its lineup of high-value-added health and nutrition-related products.

Ajinomoto Co. has been conducting Food Products and AminoScience businesses centered on proprietary leading-edge bioscience and fine chemical technologies that it has cultivated over many years through research based on amino acids. 

This closely follows Ajinomoto’s completion of procedures for the acquisition of all shares of Labeyrie Traiteur Surgelés S.A.S. (LTS) through its consolidate subsidiary Ajinomoto Foods Europe S.A.S. in accordance with details announced on July 20, 2017.

Related Articles

Nutrition & Health News

Levels of leucine in whey protein found to have limited effect on post-exercise responses

24 Nov 2017 --- Despite higher-magnitude increases in blood leucine concentrations with native whey, it was not superior to regular whey (WPC-80) when it came to the effect on muscle protein synthesis and phosphorylation of the protein p70S6K during a five-hour post-exercise period. This is according to a study published in the Journal of the International Society of Sports Nutrition.

Nutrition & Health News

Lycored to showcase fortified fruit gummies with carotenoid-derived colors

24 Nov 2017 --- Lycored has announced that it is to demonstrate at Food Ingredients Europe this year how its carotenoid-derived colors are perfect for fruit gummies. The global carotenoid supplier will be handing out fortified gummies in six different fruit flavors. Their colors are achieved using Tomat-O-Red (Lycored’s range of reds to pink from tomato-derived Lycopene) and Lyc-O-Beta (yellows and oranges from BetaCarotene).

Nutrition & Health News

Kellogg’s launches organic and vegan plant-based “no added sugar” cereals

24 Nov 2017 --- Kellogg’s is to enter the organic and vegan foods market with a new range of, plant-based cereals under the W.K.Kellogg brand. The five-strong range – including two “No Added Sugar” granolas – will be completely unique to the cereal market offering differentiated natural flavors, according to Kellogg’s.

Nutrition & Health News

Benefits of coffee consumption noted in BMJ amid coffee’s strong showing in marketplace

23 Nov 2017 --- Drinking coffee is “more likely to benefit health than to harm it” for a range of health outcomes, according to researchers in The BMJ today. The researchers’ findings only enhance a good period for coffee products, as Innova Market Insights’ top trends for 2018 note that coffee is clearly trending, especially among Millennial and Generation Z consumers.

Food Ingredients News

A&B achieves probiotic patent for treatment of chronic digestive diseases

22 Nov 2017 --- A&B Ingredients’ probiotic PA5051 has been issued a new patent as a method for treatment of chronic digestive diseases. The new patent covers both inflammatory bowel disorder (IBD) and nonspecific enteropathy (NEP), and can be used as a treatment for both humans and animals.

More Articles
URL : http://www.nutritioninsight.com:80/news/ajinomoto-enters-us-medical-foods-market-with-cambrooke-therapeutics-acquisition.html